These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26826030)

  • 21. Knockout Zbtb33 gene results in an increased locomotion, exploration and pre-pulse inhibition in mice.
    Kulikov AV; Korostina VS; Kulikova EA; Fursenko DV; Akulov AE; Moshkin MP; Prokhortchouk EB
    Behav Brain Res; 2016 Jan; 297():76-83. PubMed ID: 26454239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction.
    Yee BK; Keist R; von Boehmer L; Studer R; Benke D; Hagenbuch N; Dong Y; Malenka RC; Fritschy JM; Bluethmann H; Feldon J; Möhler H; Rudolph U
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17154-9. PubMed ID: 16284244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NURR1 deficiency is associated to ADHD-like phenotypes in mice.
    Montarolo F; Martire S; Perga S; Spadaro M; Brescia I; Allegra S; De Francia S; Bertolotto A
    Transl Psychiatry; 2019 Aug; 9(1):207. PubMed ID: 31455763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine.
    Grant A; Hoops D; Labelle-Dumais C; Prévost M; Rajabi H; Kolb B; Stewart J; Arvanitogiannis A; Flores C
    Eur J Neurosci; 2007 Dec; 26(11):3215-28. PubMed ID: 18005074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
    Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC
    Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activation.
    Epping MT; Lunardi A; Nachmani D; Castillo-Martin M; Thin TH; Cordon-Cardo C; Pandolfi PP
    Cell Death Differ; 2015 Aug; 22(8):1353-62. PubMed ID: 25613376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice.
    Barbier E; Zapata A; Oh E; Liu Q; Zhu F; Undie A; Shippenberg T; Wang JB
    Neuropsychopharmacology; 2007 Aug; 32(8):1774-82. PubMed ID: 17203012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autism spectrum disorder traits in Slc9a9 knock-out mice.
    Yang L; Faraone SV; Zhang-James Y
    Am J Med Genet B Neuropsychiatr Genet; 2016 Apr; 171B(3):363-76. PubMed ID: 26755066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The amphetamine-chlordiazepoxide mixture, a pharmacological screen for mood stabilizers, does not enhance amphetamine-induced disruption of prepulse inhibition.
    Douma TN; Kolarz A; Postma Y; Olivier B; Groenink L
    Behav Brain Res; 2011 Nov; 225(1):377-81. PubMed ID: 21820012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota from persons with attention-deficit/hyperactivity disorder affects the brain in mice.
    Tengeler AC; Dam SA; Wiesmann M; Naaijen J; van Bodegom M; Belzer C; Dederen PJ; Verweij V; Franke B; Kozicz T; Arias Vasquez A; Kiliaan AJ
    Microbiome; 2020 Apr; 8(1):44. PubMed ID: 32238191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphetamine-induced locomotion in a hyperdopaminergic ADHD mouse model depends on genetic background.
    O'Neill B; Gu HH
    Pharmacol Biochem Behav; 2013 Jan; 103(3):455-9. PubMed ID: 23026058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice.
    Errico F; D'Argenio V; Sforazzini F; Iasevoli F; Squillace M; Guerri G; Napolitano F; Angrisano T; Di Maio A; Keller S; Vitucci D; Galbusera A; Chiariotti L; Bertolino A; de Bartolomeis A; Salvatore F; Gozzi A; Usiello A
    Transl Psychiatry; 2015 Feb; 5(2):e512. PubMed ID: 25689573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout.
    Hall FS; Sora I; Hen R; Uhl GR
    PLoS One; 2014; 9(12):e115009. PubMed ID: 25514162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior.
    Nakamoto C; Kawamura M; Nakatsukasa E; Natsume R; Takao K; Watanabe M; Abe M; Takeuchi T; Sakimura K
    PLoS One; 2020; 15(2):e0229288. PubMed ID: 32078638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice.
    Trinh JV; Nehrenberg DL; Jacobsen JP; Caron MG; Wetsel WC
    Neuroscience; 2003; 118(2):297-310. PubMed ID: 12699766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders.
    Ayhan Y; Abazyan B; Nomura J; Kim R; Ladenheim B; Krasnova IN; Sawa A; Margolis RL; Cadet JL; Mori S; Vogel MW; Ross CA; Pletnikov MV
    Mol Psychiatry; 2011 Mar; 16(3):293-306. PubMed ID: 20048751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schizophrenia-Like Dopamine Release Abnormalities in a Mouse Model of NMDA Receptor Hypofunction.
    Nakao K; Jeevakumar V; Jiang SZ; Fujita Y; Diaz NB; Pretell Annan CA; Eskow Jaunarajs KL; Hashimoto K; Belforte JE; Nakazawa K
    Schizophr Bull; 2019 Jan; 45(1):138-147. PubMed ID: 29394409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TSPYL1 as a Critical Regulator of TGFβ Signaling through Repression of TGFBR1 and TSPYL2.
    Tan H; Miao MX; Luo RX; So J; Peng L; Zhu X; Leung EHW; Zhu L; Chan KM; Cheung M; Chan SY
    Adv Sci (Weinh); 2024 Jun; 11(21):e2306486. PubMed ID: 38588050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes.
    Willi R; Weinmann O; Winter C; Klein J; Sohr R; Schnell L; Yee BK; Feldon J; Schwab ME
    J Neurosci; 2010 Jan; 30(2):556-67. PubMed ID: 20071518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockout of latrophilin-3 in Sprague-Dawley rats causes hyperactivity, hyper-reactivity, under-response to amphetamine, and disrupted dopamine markers.
    Regan SL; Hufgard JR; Pitzer EM; Sugimoto C; Hu YC; Williams MT; Vorhees CV
    Neurobiol Dis; 2019 Oct; 130():104494. PubMed ID: 31176715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.